=== PAGE 5 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
Kyle Hooper
CooperSurgical, Inc.
NDA 018680/MA 578

Page 5

The violations discussed in this letter do not necessarily constitute an exhaustive list. It is
your responsibility to ensure that your promotional materials for ParaGard comply with each
applicable requirement of the FD&C Act and FDA implementing regulations.

Sincerely,

{See appended electronic signature page}

Lynn Panholzer, Pharm.D.
Regulatory Review Officer
Division of Advertising & Promotion Review 2
Office of Prescription Drug Promotion

{See appended electronic signature page}

Matthew J. Falter, Pharm.D.
Team Leader
Division of Advertising & Promotion Review 2
Office of Prescription Drug Promotion

Reference ID: 4467731
